These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
3. Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions. Roald HE; Barstad RM; Kierulf P; Skjørten F; Dickinson JP; Kieffer G; Sakariassen KS Thromb Haemost; 1994 May; 71(5):655-62. PubMed ID: 8091395 [TBL] [Abstract][Full Text] [Related]
4. Response to aspirin and clopidogrel monitored with different platelet function methods. Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602 [TBL] [Abstract][Full Text] [Related]
5. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial. Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496 [TBL] [Abstract][Full Text] [Related]
6. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. Labarthe B; Théroux P; Angioï M; Ghitescu M J Am Coll Cardiol; 2005 Aug; 46(4):638-45. PubMed ID: 16098428 [TBL] [Abstract][Full Text] [Related]
8. Platelet function in clopidogrel-treated patients with acute coronary syndrome. Sibbing D; von Beckerath O; Schömig A; Kastrati A; von Beckerath N Blood Coagul Fibrinolysis; 2007 Jun; 18(4):335-9. PubMed ID: 17473574 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of ticlopidine on platelet function as assessed by three different methods. Cuyun-Lira O; Kaneko M; Takafuta T; Satoh K; Ohnishi M; Yatomi Y; Ozaki Y Eur J Pharm Sci; 2007 Jan; 30(1):21-5. PubMed ID: 17070023 [TBL] [Abstract][Full Text] [Related]
10. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Barrera-Ramirez C; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C Thromb Res; 2005; 115(1-2):101-8. PubMed ID: 15567460 [TBL] [Abstract][Full Text] [Related]
11. The Retention Index Test Homburg (RTH-II): Response to clopidogrel and comparison with aggregometry and CD62P-expression. Klinkhardt U; Wenzel E; Harder S Platelets; 2006 Feb; 17(1):42-8. PubMed ID: 16308186 [TBL] [Abstract][Full Text] [Related]
12. Does heart failure etiology, New York Heart Association class, or ejection fraction affect the ability of clopidogrel to inhibit heightened platelet activity? Malinin AI; Oshrine BR; Sane DC; O'Connor CM; Serebruany VL Blood Coagul Fibrinolysis; 2007 Mar; 18(2):91-6. PubMed ID: 17287623 [TBL] [Abstract][Full Text] [Related]
13. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome. Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Romero-Barra M; Camoin L; Lambert M; Juhan-Vague I; Bonnet JL; Alessi MC Thromb Haemost; 2007 Feb; 97(2):212-7. PubMed ID: 17264949 [TBL] [Abstract][Full Text] [Related]
14. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469 [TBL] [Abstract][Full Text] [Related]
15. Shear-induced global thrombosis test of native blood: pivotal role of ADP allows monitoring of P2Y12 antagonist therapy. Saraf S; Wellsted D; Sharma S; Gorog DA Thromb Res; 2009 Sep; 124(4):447-51. PubMed ID: 19476973 [TBL] [Abstract][Full Text] [Related]
16. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604 [TBL] [Abstract][Full Text] [Related]
17. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100). Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774 [TBL] [Abstract][Full Text] [Related]
18. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin. Dropinski J; Musial J; Jakiela B; Wegrzyn W; Sanak M; Szczeklik A Thromb Haemost; 2005 Dec; 94(6):1300-5. PubMed ID: 16411409 [TBL] [Abstract][Full Text] [Related]
19. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding. Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104 [TBL] [Abstract][Full Text] [Related]